跳至主要内容
临床试验/NCT01014377
NCT01014377已完成不适用

Assessment of the Safety of the VascuActive™ Device and Its Preliminary Efficacy on Foot Perfusion, Hemodynamics and Exercise Capacity in Patients With Peripheral Vascular Disease and Limb Ischemia

VascuActive LTD1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2009年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
15
试验地点
1
主要终点
Pain-free and Maximal walking distance

研究概览

简要总结

The purpose of this study is to assess the safety and the immediate effect of the VascuActive device on patients with peripheral vascular disease and limb ischemia.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Leg Ischemia, Fontaine grade IIa and IIb, i.e.: pain free walking distance in the range of 50 - 100 meters.
  • Absent pulses in the two foot arteries (Anterior Tibial a., Posterior Tibial a.)
  • ABI < 0.7 by Doppler, in at least one of the two foot arteries

排除标准

  • Absent femoral pulses
  • Venous insufficiency by Duplex
  • Pregnancy
  • Infectious disease
  • Malignant disease
  • Severe cardiac disease, e.g., CHF grade 3 or higher
  • Acute MI within last 3 months
  • CABG within last 3 months
  • Other severe systemic disease

结局指标

主要结局

Pain-free and Maximal walking distance

时间窗: 1 hour

次要结局

  • Skin temperature(1 hour)
  • Skin blood flow(1 hour)
  • Transcutaneous partial pressure of O2 and CO2(1 hour)

研究者

发起方
VascuActive LTD
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验

Effect of VascuActive Device on Foot Perfusion,... | 临床试验